162 related articles for article (PubMed ID: 23096037)
1. [Mexidol in the complex treatment of patients in the acute period of tick borne encephalitis].
Udintseva IN; Bartfel't NN; Zhukova NG; Poponina AM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):34-8. PubMed ID: 23096037
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
Berezhnaya SV; Yakupov EZ; Zaharov YA
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176
[TBL] [Abstract][Full Text] [Related]
3. [The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia].
Berezhnaya SV; Yakupov EZ
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):48-52. PubMed ID: 26356397
[TBL] [Abstract][Full Text] [Related]
4. [Nootropics and antioxidants in the complex therapy of symptomatic posttraumatic epilepsy].
Savenkov AA; Badalian OL; Avakian GN
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):26-34. PubMed ID: 23887448
[TBL] [Abstract][Full Text] [Related]
5. [Adaptogenic effects of mexidol in chronic cerebral ischemia].
Antipenko EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):44-9. PubMed ID: 22677755
[TBL] [Abstract][Full Text] [Related]
6. [Neuroimmune aspects of the pathogenesis and nitric oxide negative effects modifying the pathogenetic treatment of tick-borne infections].
Kon'kova-Reĭdman AB; Ratnikova LI
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2):40-5. PubMed ID: 22677664
[TBL] [Abstract][Full Text] [Related]
7. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Kutashov VA; Ulyanova OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
[TBL] [Abstract][Full Text] [Related]
8. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
Abramenko IuV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of the use of antioxidant preparation mexidol in comprehensive treatment of inflammatory diseases of parodontium].
Garazha NN; Garus IaN; Ivashova AV; Sakuro AA
Stomatologiia (Mosk); 2006; 85(6):19-21. PubMed ID: 17310943
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
Chukanova EI; Chukanova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217
[TBL] [Abstract][Full Text] [Related]
11. [Effect of mexidol on the course of post-traumatic epilepsy].
Novikov VE; Maslova NN
Eksp Klin Farmakol; 2003; 66(4):9-11. PubMed ID: 14558343
[TBL] [Abstract][Full Text] [Related]
12. [Experience with mexidol in neurological practice].
Gromova OA; Torshin IY; Stakhovskaya LV; Pepelyaev EG; Semenov VA; Nazarenko AG
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):97-107. PubMed ID: 30499505
[TBL] [Abstract][Full Text] [Related]
13. [Antioxidants in complex treatment of Parkinson's disease].
Katunina EA; Malykhina EA; Kuznetsov NV; Avakian GN; Gusev Ei; nerobkova LN; Voronina TA; Barskov IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(9):22-8. PubMed ID: 17069058
[TBL] [Abstract][Full Text] [Related]
14. [Evolution in optimization of stroke treatment].
Zhivolupov SA; Samartsev IN; Ivanova KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8 Pt 2):49-58. PubMed ID: 23390656
[TBL] [Abstract][Full Text] [Related]
15. [Preclinical and clinical studies of the efficacy of Panavir in therapy for tick-borne encephalitis].
Litvin AA; Ratnikova LI; Deriabin PG
Vopr Virusol; 2009; 54(3):26-32. PubMed ID: 19537094
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of mexidol in acute pancreatitis].
Ivanov IuV; Chudnykh SM; Mozgalin AG
Klin Med (Mosk); 2002; 80(9):44-6. PubMed ID: 12416225
[TBL] [Abstract][Full Text] [Related]
17. [Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome].
Volchegorskiĭ IA; Moskvicheva MG; Chashchina EN
Ter Arkh; 2005; 77(10):10-5. PubMed ID: 16320677
[TBL] [Abstract][Full Text] [Related]
18. [Effect of mexidol on efficacy of traditional therapy of sick sinus syndrome in adolescents].
Balykova LA
Eksp Klin Farmakol; 2003; 66(5):25-7. PubMed ID: 14650210
[TBL] [Abstract][Full Text] [Related]
19. [Effect of mexidol on oxidative stress in cerebral variant of hypertensive crisis].
Golikov AP; Golikov PP; Davydov BV; Riabinin VA; Luk'ianov MM; Kalinin AN; Klychnikova EV; Promanenkov VK
Kardiologiia; 2002; 42(3):25-9. PubMed ID: 12494182
[TBL] [Abstract][Full Text] [Related]
20. [Estimating the potential of antioxidant therapy for patients with Parkinson's disease diagnosis].
Katunina EA
Eksp Klin Farmakol; 2005; 68(5):16-8. PubMed ID: 16277203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
